QuidelOrtho Q4 results beat on both lines, but issues weak 2026 EPS guidance
2026-02-11 16:34:26 ET
More on QuidelOrtho
- QuidelOrtho: EBIT Margins In Focus As We Approach Q4 Earnings Release
- QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
- Quidel Non-GAAP EPS of $0.46 beats by $0.04, revenue of $724M beats by $23.91M
- Quidel Q4 2025 Earnings Preview
- Seeking Alpha’s Quant Rating on Quidel
Read the full article on Seeking Alpha
For further details see:
QuidelOrtho Q4 results beat on both lines, but issues weak 2026 EPS guidanceNASDAQ: QDEL
QDEL Trading
-1.39% G/L:
$19.90 Last:
730,159 Volume:
$20.06 Open:



